Vanda Pharmaceuticals (VNDA)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 12-2025 | 09-2025 | 06-2025 | 03-2025 | 12-2024 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -220,474 | -79,287 | -56,701 | -29,494 | -18,900 |
| Depreciation Amortization | 9,864 | 4,257 | 2,699 | 1,234 | 2,805 |
| Income taxes - deferred | 81,443 | -21,743 | -15,769 | -7,797 | -6,482 |
| Accounts receivable | -7,463 | -3,388 | 2,181 | 2,534 | -13,012 |
| Accounts payable and accrued liabilities | 15,820 | 6,743 | 16,966 | 5,636 | 1,708 |
| Other Working Capital | 8,308 | 5,282 | 13,408 | -1,914 | -6,558 |
| Other Operating Activity | 3,060 | 8,111 | -11,183 | -3,346 | 24,682 |
| Operating Cash Flow | $-109,442 | $-80,025 | $-48,399 | $-33,147 | $-15,757 |
| Cash Flows From Investing Activities | |||||
| PPE Investments | -998 | -896 | -735 | -436 | -4,719 |
| Purchase Of Investment | -112,379 | -110,347 | -96,300 | -43,329 | -364,773 |
| Sale Of Investment | 208,237 | 161,237 | 125,667 | 87,667 | 352,062 |
| Investing Cash Flow | $94,860 | $49,994 | $28,632 | $43,902 | $-17,430 |
| Cash Flows From Financing Activities | |||||
| Debt Issued | -1,991 | -1,351 | -834 | -409 | -155 |
| Other Financing Activity | -915 | -915 | -915 | -915 | 0 |
| Financing Cash Flow | $-2,906 | $-2,266 | $-1,749 | $-1,324 | $-155 |
| Exchange Rate Effect | 23 | 3 | 183 | 49 | -163 |
| Beginning Cash Position | 102,785 | 102,785 | 102,785 | 102,785 | 136,290 |
| End Cash Position | 85,320 | 70,491 | 81,452 | 112,265 | 102,785 |
| Net Cash Flow | $-17,465 | $-32,294 | $-21,333 | $9,480 | $-33,505 |
| Free Cash Flow | |||||
| Operating Cash Flow | -109,442 | -80,025 | -48,399 | -33,147 | -15,757 |
| Capital Expenditure | -998 | -896 | -735 | -436 | -4,719 |
| Free Cash Flow | -110,440 | -80,921 | -49,134 | -33,583 | -20,476 |